Xilio Therapeutics, Inc. · NASDAQ:XLO
BCLS II Equity Opportunities, LP reported a 9.99% stake in Xilio Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
BCLS II Equity Opportunities, LP reported a 9.99% stake in Xilio Therapeutics, Inc., 664,021 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 664,021
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BCLS II Equity Opportunities, LP | 9.99% | 664,021 |
| Bain Capital Life Sciences Fund II, L.P. | 0% | 0 |
| BCIP Life Sciences Associates, LP | 0% | 0 |